Letter

Lipid lowering drugs in diabetes: Absolute risk reduction is what counts

BMJ 2006; 332 doi: 10.1136/bmj.332.7552.1272-a (Published 25 May 2006)
Cite this as: BMJ 2006;332:1272.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. L S Lewis, general practitioner (sam@garthnewydd.freeserve.co.uk)
  1. Surgery, Newport, Pembrokeshire SA42 0TJ

    EDITOR—Costa et al draw the principal conclusion that diabetic patients benefit more, in both primary and secondary prevention.1 But it is abundantly clear from their own analysis that the relative risk reduction was …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular